Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease

Summary

The purpose of the study is to learn whether people who are experiencing an MCD (multicentric Castleman's Disease) flare will improve after taking valganciclovir. MCD is a type of inflammatory disease associated with Human Herpesvirus 8 (HHV-8). Valganciclovir is FDA approved for treating a different type of Human Herpesvirus, but not approved for the treatment of HHV-8. It is therefore considered experimental in this study.

Timeline

Start

2008-12

Primary completion

2009-05

Completion

2009-05

Drugs

Indications